NIRAPARIB Pharmacologic Class Indexing
- Class set ID
- ad599061-f477-4f76-b5df-bfcacdf64ccf
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017 | GlaxoSmithKline LLC | 20260327 | 9 |
| These highlights do not include all the information needed to use AKEEGA safely and effectively. See full prescribing information for AKEEGA. AKEEGA ® (niraparib and abiraterone acetate) tablets, for oral use Initial U.S. Approval: 2023 | Janssen Biotech, Inc. | Shanghai SynTheAll Pharmaceutical Co., Ltd. | Changzhou SynTheAll Pharmaceutical Co., Ltd. | Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. | Zhejiang Xianju Junye Pharmaceutical Co., Ltd. | Pharmacia & Upjohn Company LLC | Janssen Pharmaceutica NV | Patheon France S.A.S | Janssen Cilag SpA | Johnson & Johnson Private Limited | 20251218 | 3 |